| ID: 129929591 | ATAC-STARR-seq lymphoblastoid active region 317 [Homo sapiens (human)] | Chromosome 1, NC_000001.11 (20195267..20195326) | | |
| ID: 129929590 | ATAC-STARR-seq lymphoblastoid active region 316 [Homo sapiens (human)] | Chromosome 1, NC_000001.11 (20171458..20171687) | | |
| ID: 127267924 | H3K4me1 hESC enhancer GRCh37_chr1:20479806-20480357 [Homo sapiens (human)] | Chromosome 1, NC_000001.11 (20153313..20153864) | | |
| ID: 127267923 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr1:20476004-20476630 [Homo sapiens (human)] | Chromosome 1, NC_000001.11 (20149511..20150137) | | |
| ID: 127267922 | H3K4me1 hESC enhancer GRCh37_chr1:20474795-20475295 [Homo sapiens (human)] | Chromosome 1, NC_000001.11 (20148302..20148802) | | |
| ID: 127267921 | H3K4me1 hESC enhancer GRCh37_chr1:20468424-20468924 [Homo sapiens (human)] | Chromosome 1, NC_000001.11 (20141931..20142431) | | |
| ID: 126805648 | CDK7 strongly-dependent group 2 enhancer GRCh37_chr1:20537509-20538708 [Homo sapiens (human)] | Chromosome 1, NC_000001.11 (20211016..20212215) | | |
| ID: 126805647 | CDK7 strongly-dependent group 2 enhancer GRCh37_chr1:20511679-20512878 [Homo sapiens (human)] | Chromosome 1, NC_000001.11 (20185186..20186385) | | |
| ID: 117779438 | uncharacterized LOC117779438 [Homo sapiens (human)] | Chromosome 1, NC_000001.11 (20154214..20160568) | | |
| ID: 105376826 | uncharacterized LOC105376826 [Homo sapiens (human)] | Chromosome 1, NC_000001.11 (20210715..20213349, complement) | | |
| ID: 105376825 | uncharacterized LOC105376825 [Homo sapiens (human)] | Chromosome 1, NC_000001.11 (20197306..20202827) | | |
| ID: 391013 | phospholipase A2 group IIC [Homo sapiens (human)] | Chromosome 1, NC_000001.11 (20163055..20186518, complement) | UBXN10-AS1 | |
| ID: 127733 | UBX domain protein 10 [Homo sapiens (human)] | Chromosome 1, NC_000001.11 (20183331..20196050) | UBXD3 | 616783 |
| ID: 64600 | phospholipase A2 group IIF [Homo sapiens (human)] | Chromosome 1, NC_000001.11 (20139323..20150381) | GIIFsPLA2, sPLA2-IIF | 616793 |